1. "Department of Medicine"
Formats
  1. Journal Article (19347)
  2. Meeting Abstract (15822)
  3. Review (1102)
  4. Book Section (924)
  5. Editorial (580)
  6. Research Letter (301)
  7. Conference Paper (299)
  8. Guidelines (285)
  9. Correspondence (226)
  10. Miscellaneous (87)
  11. Book Whole (61)
Groups
  1. Department of Medicine (39034)
  2. Solid Tumor Oncology Division (22035)
  3. Hematologic Malignancies, Division of (13003)
  4. Center for Hematologic Malignancies (10841)
  5. GSK Faculty (10529)
  6. Survivorship Research (9202)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Sergio Giralt (1050)
  4. Miguel-Angel Perales (913)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (642)
  2. 2024 (2141)
  3. 2023 (2451)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2560)

More Years

Publications
  1. Journal of Clinical Oncology (6050)
  2. Blood (3572)
  3. Annals of Oncology (1395)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (890)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6364)
  2. Elsevier Inc. (4610)
  3. American Society of Hematology (3843)
  4. American Association for Cancer Research (2879)
  5. Oxford University Press (2271)
  6. Nature Publishing Group (2080)

More Publishers

Results (39034)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF)
    Meeting Abstract

    Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent deletion of BRCA2 and RB1 and aggressive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Nanjangud, G.; Chadalavada, K.; Atiq, M. O.; Komura, K.; Yoshikawa, Y.; Khan, N.; Du, S. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Evaluation of predictive biomarkers for nivolumab in metastatic clear cell renal cell carcinoma (mccRCC) using RECIST and immune-related (IR) RECIST
    Meeting Abstract

    Pignon, J. C.; Jegede, O.; Horak, C.; Wind-Rotolo, M.; Catalano, P. J.; Grosha, J.; Flaifel, A.; Novak, J.; Mahoney, K. M.; Freeman, G. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic alterations to refine prognostication of patients with metastatic renal cell carcinoma
    Meeting Abstract

    Bosse, D.; Xie, W.; Lalani, A. K. A.; de Velasco, G.; Voss, M. H.; Tannir, N. M.; Tamboli, P.; Appleman, L. J.; Rathmell, K.; Heng, D. Y. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Interleukin-12 armored chimeric antigen receptor (CAR) T cells for heterogeneous antigen-expressing ovarian cancer
    Meeting Abstract

    Yeku, O. O.; Purdon, T.; Spriggs, D. R.; Brentjens, R. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A single-arm, phase II study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)
    Meeting Abstract

    McArthur, H. L.; Barker, C. A.; Gucalp, A.; Lebron-Zapata, L.; Wen, Y. H.; Phung, A.; Rodine, M.; Arnold, B.; Zhang, Z.; Ho, A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pilot study of gemcitabine, nab-paclitaxel, PEGPH20, and rivaroxaban for advanced pancreatic adenocarcinoma: An interim analysis
    Meeting Abstract

    Yu, K. H.; Mantha, S.; Tjan, C.; Kaufmann, E. S.; Brenner, R.; Lowery, M. A.; Ku, G. Y.; Raj, N. P.; Shcherba, M.; Goldberg, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A randomized phase 2 study of durvalumab monotherapy and in combination with tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS study
    Meeting Abstract

    O'Reilly, E. M.; Oh, D. Y.; Dhani, N.; Renouf, D. J.; Lee, M. A.; Sun, W.; Fisher, G. A.; Hezel, A. F.; Chang, S. C.; Vlahovic, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prospective analysis of somatic and germline genetic alterations in patients with ampullary carcinomas
    Meeting Abstract

    Wong, W.; O'Reilly, E. M.; Varghese, A. M.; Yu, K. H.; Iacobuzio-Donahue, C. A.; Shia, J.; Klimstra, D.; Allen, P. J.; Lowery, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 2 trial of CRS-207 and pembrolizumab in adults with recurrence of metastatic gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinomas
    Meeting Abstract

    Kelly, R. J.; Abrams, T. A.; Catenacci, D. V. T.; Wainberg, Z. A.; Lin, B. S. L.; Enstrom, A.; Whiting, C. C.; Wason, P.; Murphy, A.; Brockstedt, D. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save